Abstract
Objective: E-sclectin is an endothclial cell-specific membrane glycoprotein that participates in leukocyte adhesion and has also been suggested to function in angiogenesis. To gain further insights into E-selectin, we analyzed E-selectin polypeptide in proliferating versus quiescent bovine capillary endothelial cells and its expression as a function of the cell cycle. Methods: E-selectin polypeptide was analyzed by immunoadsorption from 35Scysteine-labeled endothelial cells, by enzyme-ilinked immunosorbent assay, and by fluorescence-activated cell sorting. The distribution of endothelial cells in G0/G1, S, and G2/M phases of the cell cycle was determined using propidium iodide staining of DNA. Results: E-selectin was upregulated in subconfluent proliferating bovine capillary endothelial cells compared to confluent quiescent cultures. The upregnlation was independent of activation in that E-selectin was further increased by treatment with tumor necrosis factor α or lipopolysaccharide. In contrast to E-selectin, P-selectin and platelet-endothelial cell adhesion molecule-1 did not appear to be regulated by the growth state of the endothelial cells. The distribution of E-selectin-positive cells in G0G1, S, and G2/M phases of the cell cycle differed from E-selectin-negative cells in that more of the E-selectin-positive cells were in G2 and M. Conclusions: Increased E-sclectin expression under noninflammatory conditions is correlated with cellular proliferation and G2/M phases of the cell cycle. The expression of E-selectin in proliferating endothelial cells in vitro is consistent with the presence of E-selectin in proliferating endothelial cells in vivo (Kräling et al. [18]).
Author supplied keywords
Cite
CITATION STYLE
Bischoff, J., Brasel, C., Kräling, B., & Vranovska, K. (1997). E-selectin is upregulated in proliferating endothelial cells in vitro. Microcirculation, 4(2), 279–287. https://doi.org/10.3109/10739689709146791
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.